Filter
638
Filtered Results: 638
Text search:
Mild
COVID
Featured
Recommendations
109
New Publications
2
Language
Document type
Guidelines
252
Studies & Reports
135
Fact sheets
86
Manuals
51
Strategic & Response Plan
39
Situation Updates
23
Training Material
15
Infographics
10
Brochures
7
No document type
7
Resource Platforms
6
Videos
4
Online Courses
3
Countries / Regions
Global
32
India
28
South Africa
25
Germany
24
Syria
22
Latin America and the Carribbean
22
Western and Central Europe
22
Brazil
20
Middle East and North Africa
18
Russia
18
Africa
15
West and Central Africa
15
East and Southern Africa
15
Eastern Europe and Central Asia
14
Kenya
11
South–East Asia Region
10
Yemen
9
South Sudan
9
Mozambique
6
Bangladesh
6
Nigeria
5
Western Pacific Region
5
Vietnam
5
Angola
5
Malawi
4
Jordan
4
United Kingdom
4
Eastern Europe
4
Tajikistan
3
Ukraine
3
Ghana
3
China
3
Chile
3
Philippines
3
Guinea-Bissau
3
Congo, Democratic Republic of
3
Paraguay
3
Lebanon
3
Palestine
3
Ethiopia
3
Nepal
2
Colombia
2
Turkey
2
Sierra Leone
2
Kazakhstan
2
Laos
2
Burkina Faso
2
Afghanistan
2
Zimbabwe
2
Cambodia
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Iraq
2
Ecuador
2
Pakistan
2
North Macedonia
1
Switzerland
1
Thailand
1
Serbia
1
Australia
1
Benin
1
Rwanda
1
Fiji
1
Singapore
1
Kyrgyzstan
1
Congo-Brazzaville
1
Uzbekistan
1
Peru
1
Austria
1
Armenia
1
Asia
1
Venezuela
1
Tanzania
1
Saudi Arabia
1
North America
1
France
1
Spain
1
South Korea
1
Bolivia
1
Argentina
1
Uganda
1
Moldova
1
Sri Lanka
1
Egypt
1
Sudan
1
Georgia
1
Mali
1
Chad
1
Somalia
1
Liberia
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
273
Clinical Guidelines
33
Public Health
27
Women & Child Health
19
Key Resources
17
Capacity Building
8
Pharmacy & Technologies
5
Toolboxes
COVID-19
464
NCDs
21
Rapid Response
13
Mental Health
12
NTDs
12
Refugee
11
Planetary Health
11
Conflict
10
TB
8
Caregiver
8
HIV
7
Disability
6
Pharmacy
5
AMR
5
Health Financing Toolbox
4
Natural Hazards
3
Cholera
1
Ebola & Marburg
1
Zika
1
Global Health Education
1
Interim guidance, 12 August 2020This interim guidance has been updated with advice on safe and appropriate home care for patients with coronavirus disease 2019 (COVID-19) and on the public health measures related to the management of their contacts.
BMJ Global Health2020;5:e002786. doi:10.1136/bmjgh-2020-002786
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R...
scientific brief, 2 March 2022
Lancet Respir Med 2020Published OnlineMarch 20, 2020 https://doi.org/10.1016/S2213-2600(20)30134-
This guide focuses on three main areas: how to support a person whose condition warrants home care because of non-severe symptoms and home care is recommended by local jurisdictions; how to prevent the spread of COVID-19 in the home; and how to provide emotional support to family members. While this...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr...
Results of rapid assessment
The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey. The survey of 130 countries provides the first global data showing the devastating...
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises. WHO continues to support countries in adjusting COVID-19 strategies to reflect succ...
Recommended practices booklet (April 2020)
The set includes 10 Counselling Cards and a Recommended Practices Booklet. Infant and young child feeding (IYCF) counselling in the context of COVID-19 remains a critical nutrition intervention for the protection and support of pregnant women, caregivers, ...
The following protocol has been designed to investigate the extent of infection, as determined by seropositivity in the general population, in any country in which COVID-19 virus infection has been reported. Each country may need to tailor some aspects of this protocol to align with public health, l...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. 30 μg von BioNTech/Pfizer...
